Global Infection Control Market to Reach US$62.3 Billion by the Year 2026

Abstract: Global Infection Control Market to Reach US$62. 3 Billion by the Year 2026 . Infection control plays a critical role in activities related to sterile processing of devices, in addition to disposal and decontamination of potentially infectious bio-hazardous waste.

New York, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Infection Control Industry" - https://www.reportlinker.com/p06041857/?utm_source=GNW
The market for infection control is expected to witness rapid growth in the coming years due to the rapidly growing incidence of HAIs (Hospital Acquired Infections) and rising number of surgeries. Healthcare Associated Infections (HAIs) constitute one of the leading causes of death globally and constitutes for nearly 100,000 deaths every year in the US alone. Other market growth promoting factors include rising geriatric population, especially in developed countries, and increasing prevalence of chronic diseases. Market growth is also being positively influenced by the rising focus of nations on disinfection and sterilization. Pharmaceutical companies, medical device companies and hospitals are also increasingly outsourcing such sterilization jobs, which is also contributing to market growth. The market is witnessing the development of advanced sterilization equipment in response to the advanced medical equipment being developed. Factors, such as increasing public and professional awareness, need for reducing healthcare costs, shifting of patient care from acute care to alternate sites, growth of less invasive surgical and diagnostic procedures, and the rising number of transmittable and antibiotic-resistant infectious diseases, have led to the increased demand for safe and efficient sterilization equipment.

Amid the COVID-19 crisis, the global market for Infection Control estimated at US$40.3 Billion in the year 2020, is projected to reach a revised size of US$62.3 Billion by 2026, growing at a CAGR of 7.2% over the analysis period. Protective Barriers, one of the segments analyzed in the report, is projected to grow at a 9.2% CAGR to reach US$26.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sterilization Products & Services segment is readjusted to a revised 7.2% CAGR for the next 7-year period. Growing demand for surgical drapes, gowns and face masks and such other medical nonwovens, amid the pandemic, has been contributing to growth of protective barriers.

The U.S. Market is Estimated at $12.9 Billion in 2021, While China is Forecast to Reach $9.2 Billion by 2026

The Infection Control market in the U.S. is estimated at US$12.9 Billion in the year 2021. The country currently accounts for a 27.5% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$9.2 Billion in the year 2026 trailing a CAGR of 8.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR while Rest of European market (as defined in the study) will reach US$3.4 Billion by the end of the analysis period. North America is the largest regional market for infection control attributed to increased adoption of disinfection and sterilization products and services and also increased focus of the population here on disease prevention and following healthy lifestyles. Another lucrative market for infection control is Asia-pacific where increasing HAIs incidence, especially in fast emerging countries, is leading to increased adoption of disinfection and sterilization equipment and services.

Cleaning & Disinfection Products Segment to Reach $10.5 Billion by 2026

In the global Cleaning & Disinfection Products segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.9 Billion in the year 2020 will reach a projected size of US$8.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2026.


Select Competitors (Total 145 Featured)

• 3M Company

• Advanced Sterilization Products

• Belimed AG

• Cantel Medical Corporation

• Ecolab, Inc.

• Getinge AB (Getinge Group)

• Halyard Health, Inc.

• Matachana Group

• Metrex Research LLC

• Pal International Ltd.

• Reckitt Benckiser Group PLC

• Sotera Health LLC

• Steris

Read the full report: https://www.reportlinker.com/p06041857/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
The Never-Ending ?Race? Between the Virus & Vaccines Continues.
Amidst this Chaotic Battle, Where is the World Economy Heading
Now & Beyond?
Omicron Spreads Panic Worldwide; Omicron Variant Brings Back
Memories & Fears of the Worst Part of the 2020 Pandemic
EXHIBIT 1: Time is of Essence! What We Know So Far - ?Vaccine
Efficiency against New Strains is Decreasing?
South Africa: Omicron?s Origin Location
Short-term Impact of Omicron on Travel
Financial Impact
Scientists Seek to Gather More Information on Omicron
Pharma Firms Aim to Improve Existing Vaccines to Counter Omicron
Omicron: Impact on Travel Industry
Steps taken by the Countries to Prevent Transmission of Omicron
Variant
With IMF Making an Upward Revision of Global GDP for 2021,
Companies Are Bullish About an Economic Comeback Despite a
Continuing Pandemic
EXHIBIT 2: A Strong Yet Exceedingly Patchy & Uncertain Recovery
Shaped by New Variants Comes Into Play: World Economic Growth
Projections (Real GDP, Annual % Change) for 2020 through 2022
Impact of COVID-19 on Infection Control Market
Global Market Analysis and Prospects
Product and End-use Segments
Regional Market Analysis
Market Growth Restraining Factors
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Sterilization Equipment Market Witnesses Rapid Growth
Major Players in the Global Sterilization Equipment Market
Low-Temperature Sterilization Gains Ground
Leading Players in the Low-Temperature Sterilization Market
Emergence of Outsourcing Trend Bodes Well for Sterilization
Services
E-beam Sterilization of Medical Devices Registers Rapid Growth
Endoscope Contamination - A Major Health Hazard Driving the
Demand for Sterilization Equipment
Increasing Need to Reduce Hospital-Acquired Infections Propel
Market Demand
EXHIBIT 3: Leading Nosocomial Infections in the US: Percentage
Breakdown of Healthcare Cost by Infection Type
EXHIBIT 4: Central Line-Associated Bloodstream Infection:
(CLABSI) SIR in the US Hospitals: 2010 to 2016
EXHIBIT 5: Catheter-associated Urinary Tract Infection (CAUTI)
SIR in the US Hospitals: 2010 to 2016
EXHIBIT 6: Surgical Site Infections SIR of Abdominal
Hysterectomy in the US Hospitals: 2010-2021
Government Support to Ensure Infection Control in Clinical
Settings to Boost Demand for Infection Control Products
Increasing Prevalence of Chronic Disorders, Rise in Surgical
Procedures and the Need to Prevent Transmission of Infections
Fuels Market Growth
EXHIBIT 7: No. of Surgical Procedures in Aging Population in
the US (2016, 2018 & 2022)
Aging Population - A Key Growth Driver
EXHIBIT 8: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
Rising Demand for Medical Devices Augurs Well for the Market
COVID-19 Pandemic Triggers the Onset of Face Mask Era
Respirator Mask Records Significant Growth
Designers Revamp Face Masks into a Fashion Accessory
Surgical Drapes and Gowns: Indispensable for Safe Healthcare
Surgical Gowns Market: Stable Growth Outlook
High Demand for Disposable Drapes and Gowns
COVID-19 Outbreak Resulted in Massive Spike in Disposable
Gloves Market
Growth in Medical Device Reprocessing to Offer New Areas of Growth
UV Disinfection Soaks up Limelight with COVID-19-Induced
Disinfection Focus
Improving Healthcare Expenditure to Bode Well for Market Growth
EXHIBIT 9: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
Technological Advancements
India Focuses on Development of COVID-19 Relevant Technologies
for Disinfection and Sterilization
Sealive?s Biovector Sterilization Technology for more Effective
Inactivation of Viruses and Microorganisms
Introduction of Business-Friendly Policies and Guidelines Fuel
Demand for Eco-Friendly Medical Sterilization Equipment
Challenges and Future Prospects

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Infection Control
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Infection Control by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Infection Control by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Current & Future Analysis for Protective
Barriers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Protective Barriers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Protective Barriers by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Current & Future Analysis for Sterilization
Products & Services by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Sterilization Products &
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Sterilization Products &
Services by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 10: World Current & Future Analysis for Cleaning &
Disinfection Products by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Cleaning & Disinfection
Products by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Cleaning & Disinfection
Products by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 13: World Current & Future Analysis for Endoscope
Reprocessing Products by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Endoscope Reprocessing
Products by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Endoscope Reprocessing
Products by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 16: World Current & Future Analysis for Other Products &
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Products & Services
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other Products &
Services by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 19: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Current & Future Analysis for Pharma & Medical
Device Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Pharma & Medical Device
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Pharma & Medical Device
Companies by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Infection Control
by Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Infection Control by Products &
Services - Protective Barriers, Sterilization Products &
Services, Cleaning & Disinfection Products, Endoscope
Reprocessing Products and Other Products & Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 31: USA Current & Future Analysis for Infection Control
by End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 32: USA Historic Review for Infection Control by End-Use -
Hospitals & Clinics, Pharma & Medical Device Companies and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Infection
Control by Products & Services - Protective Barriers,
Sterilization Products & Services, Cleaning & Disinfection
Products, Endoscope Reprocessing Products and Other Products &
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 37: Canada Current & Future Analysis for Infection
Control by End-Use - Hospitals & Clinics, Pharma & Medical
Device Companies and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 38: Canada Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 39: Canada 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Infection Control
by Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 43: Japan Current & Future Analysis for Infection Control
by End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 44: Japan Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 45: Japan 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

CHINA
Table 46: China Current & Future Analysis for Infection Control
by Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 49: China Current & Future Analysis for Infection Control
by End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 50: China Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 51: China 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

EUROPE
Table 52: Europe Current & Future Analysis for Infection
Control by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 53: Europe Historic Review for Infection Control by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Infection Control by
Geographic Region - Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 55: Europe Current & Future Analysis for Infection
Control by Products & Services - Protective Barriers,
Sterilization Products & Services, Cleaning & Disinfection
Products, Endoscope Reprocessing Products and Other Products &
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 58: Europe Current & Future Analysis for Infection
Control by End-Use - Hospitals & Clinics, Pharma & Medical
Device Companies and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Europe Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 60: Europe 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

FRANCE
Table 61: France Current & Future Analysis for Infection
Control by Products & Services - Protective Barriers,
Sterilization Products & Services, Cleaning & Disinfection
Products, Endoscope Reprocessing Products and Other Products &
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 64: France Current & Future Analysis for Infection
Control by End-Use - Hospitals & Clinics, Pharma & Medical
Device Companies and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: France Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 66: France 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Infection
Control by Products & Services - Protective Barriers,
Sterilization Products & Services, Cleaning & Disinfection
Products, Endoscope Reprocessing Products and Other Products &
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 70: Germany Current & Future Analysis for Infection
Control by End-Use - Hospitals & Clinics, Pharma & Medical
Device Companies and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: Germany Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 72: Germany 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Infection Control
by Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 76: Italy Current & Future Analysis for Infection Control
by End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 77: Italy Historic Review for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 78: Italy 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Infection Control by
Products & Services - Protective Barriers, Sterilization
Products & Services, Cleaning & Disinfection Products,
Endoscope Reprocessing Products and Other Products & Services -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Infection Control by Products &
Services - Protective Barriers, Sterilization Products &
Services, Cleaning & Disinfection Products, Endoscope
Reprocessing Products and Other Products & Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Infection Control by
Products & Services - Percentage Breakdown of Value Revenues
for Protective Barriers, Sterilization Products & Services,
Cleaning & Disinfection Products, Endoscope Reprocessing
Products and Other Products & Services for the Years 2012, 2021 &
2027

Table 82: UK Current & Future Analysis for Infection Control by
End-Use - Hospitals & Clinics, Pharma & Medical Device
Companies and Other End-Uses - Independent Analysis of Annual
Revenues in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 83: UK Historic Review for Infection Control by End-Use -
Hospitals & Clinics, Pharma & Medical Device Companies and
Other End-Uses Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for Infection Control by
End-Use - Percentage Breakdown of Value Revenues for Hospitals &
Clinics, Pharma & Medical Device Companies and Other End-Uses
for the Years 2012, 2021 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for Infection Control

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06041857/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001